Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-13

Clinical Trial Update: A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4

View source ↗

Summary

A natural history study in participants with congenital myasthenic syndromes caused by mutations in DOK7, MUSK, AGRN, or LRP4 is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: argenx | Conditions: Congenital Myasthenic Syndrome | Status: RECRUITING